etoposide has been researched along with Bacterial Infections, Gram-Positive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, P; Dayao, Z; Hu, S; Lynch, D; Rojas Hernandez, CM | 1 |
| Creutzig, U; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Reinhardt, D; Varwig, D | 1 |
1 review(s) available for etoposide and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Cisplatin; Cytarabine; Enterococcus faecalis; Etoposide; Fatal Outcome; Fever; Gram-Positive Bacterial Infections; Hodgkin Disease; Humans; Jaundice; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Pancytopenia; Rituximab | 2016 |
1 other study(ies) available for etoposide and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteria; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Down Syndrome; Etoposide; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid; Male; Mitoxantrone; Neutropenia; Prospective Studies; Retrospective Studies; Thioguanine | 2004 |